Hsiao Lieu

VP, Clinical Research, CAPRICOR THERAPEUTICS, INC.

Companies

NGM Biopharmaceuticals (United States)SVP, Chief Medical Officer Apr 14, 2020 to Apr 8, 2024¹
CAPRICOR THERAPEUTICS, INC.VP, Clinical Research Jul 20, 2009 to Apr 2, 2012²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

NGM Biopharmaceuticals (United States)0 shares³Apr 5, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Apr 5, 2024U 19,349 shares of NGM Biopharmaceuticals (United States)³
Jan 16, 2024Shares withheld for tax 5,430 shares at $1.34 of NGM Biopharmaceuticals (United States)⁴
Mar 2, 2023Granted 53,000 shares of NGM Biopharmaceuticals (United States)⁵
Oct 5, 2021Sold 2,000 shares at $22.00 of NGM Biopharmaceuticals (United States)⁶
Oct 5, 2021Exercised options 2,000 shares at $12.06 of NGM Biopharmaceuticals (United States)⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARNGM Biopharmaceuticals (United States), SVP, Chief Medical Officer
2
SEC EDGARCAPRICOR THERAPEUTICS, INC., VP, Clinical Research
3
SEC EDGARNGM Biopharmaceuticals (United States) shares after the filing of Apr 5, 2024
4
SEC EDGARForm 4 filed Jan 18, 2024
5
SEC EDGARForm 4 filed Mar 6, 2023
6
SEC EDGARForm 4 filed Oct 7, 2021